SCHEMBL183395

SCHEMBL183395

CCc1cc(C)c(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922006 0.80 TLR8 (0.37)
SCHEMBL22789194 0.77 ALDH1A1 (0.33)
SCHEMBL20419311 0.77
SCHEMBL3906982 0.77
SCHEMBL15151077 0.77
SCHEMBL4301123 0.77
SCHEMBL14034872 0.77
SCHEMBL5162978 0.75
SCHEMBL12151360 0.75
SCHEMBL17428929 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US claimed
WO-2022120207-A1 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX UNIVERSITY OF MARYLAND, BALTIMORE (US) 2022-06-09 WO disclosed
US-20210292285-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC (US) 2021-09-23 US disclosed
EP-3541792-B1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 EP disclosed
US-20190192532-A1 COMBINATION THERAPY OF BROMODOMAIN INHIBITORS AND CHECKPOINT BLOCKADE PETER MACCALLUM CANCER INSTITUTE (AU) 2019-06-27 US disclosed
EP-2621979-B1 BIOCOMPOSITE PANEL ROEMMLER H RESOPAL WERK GMBH (DE) 2015-05-06 EP disclosed
US-8883788-B2 Fused heterocyclic ring compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-11-11 US disclosed
US-20130295399-A1 BIOCOMPOSITE PANEL RESOPAL GMBH (DE) 2013-11-07 US disclosed
EP-2621979-A1 BIOCOMPOSITE PANEL RESOPAL GMBH (DE) 2013-08-07 EP disclosed
US-20130137700-A1 FUSED HETEROCYCLIC RING COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-05-30 US disclosed
EP-2010289-B1 BENZOAZEPIN-OXY-ACETIC ACID DERIVATIVES AS PPAR-DELTA AGONISTS USED FOR THE INCREASE OF HDL-C, LOWER LDL-C AND LOWER CHOLESTEROL JANSSEN PHARMACEUTICA NV (BE) 2011-11-30 EP disclosed
WO-2011096812-A1 METHOD AND APPARATUS FOR MODIFYING WOOD, AND WOOD PRODUCT VIA INGENIO B.V. (NL) 2011-08-11 WO disclosed
US-7696226-B2 HIV protease inhibiting compounds ABBOTT LABORATORIES (US) 2010-04-13 US disclosed
US-20100062276-A1 METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED TRANSFURANS CHEMICALS (BE) 2010-03-11 US disclosed
WO-2009145357-A1 IN 1-POSITION DURCH EINEN RING SUBSTITUIERTE BENZO [1, 4] DIAZEPINE ZUR VERWENDUNGS ALS ANTIDEPRESSIVA OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-03 WO disclosed
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US disclosed
EP-2035198-A1 METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED Transfurans Chemicals (BE) 2009-03-18 EP disclosed
WO-2007147804-A1 METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED TRANSFURANS CHEMICALS (BE) 2007-12-27 WO disclosed
WO-2007121432-A2 BENZOAZEPIN-OXY-ACETIC ACID DERIVATIVES AS PPAR-DELTA AGONISTS USED FOR THE INCREASE OF HDL-C, LOWER LDL-C AND LOWER CHOLESTEROL JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-25 WO disclosed
US-20050159469-A1 HIV protease inhibiting compounds ABBVIE INC. 2005-07-21 US disclosed